Detalhe da pesquisa
1.
FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity.
Nat Commun;
15(1): 4590, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38816360
2.
Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
Eur Radiol;
2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514481
3.
Radiomics and dosiomics for predicting radiation-induced hypothyroidism and guiding intensity-modulated radiotherapy.
iScience;
26(12): 108394, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047064
4.
Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma.
Oral Oncol;
147: 106583, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837738
5.
Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort study.
EClinicalMedicine;
63: 102202, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680944
6.
Clinical characteristics, prognostic factors, and treatment modalities for head and neck lymphoepithelioma-like carcinoma: A real-world study from southern China.
Radiother Oncol;
187: 109814, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480992
7.
Deep learning-based precise prediction and early detection of radiation-induced temporal lobe injury for nasopharyngeal carcinoma.
EClinicalMedicine;
58: 101930, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090437
8.
FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway.
J Transl Med;
21(1): 134, 2023 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814284
9.
Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys;
115(5): 1291-1300, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462689
10.
Benefit of [18F] FDG PET/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging;
50(3): 881-891, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301324
11.
Role of postoperative chemoradiotherapy in head and neck cancer without positive margins or extracapsular extension: a propensity score-matching analysis.
Radiat Oncol;
17(1): 180, 2022 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372901
12.
Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma.
Eur Radiol;
32(6): 3649-3660, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989842
13.
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging;
49(3): 980-991, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468782
14.
Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity-modulated radiotherapy era.
Cancer Med;
11(4): 1109-1118, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953045
15.
Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis.
Ann Transl Med;
9(5): 391, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33842612
16.
Effect of Induction Chemotherapy in Nasopharyngeal Carcinoma: An Updated Meta-Analysis.
Front Oncol;
10: 591205, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33489889
17.
A Pairwise Meta-Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma.
Oncologist;
24(4): 505-512, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782977